The euro is on the front foot
The euro is on the front foot during early Thursday trading, gaining ground on both the dollar and the pound. The single currency’s strength comes on the back of positive developments about the availability of vaccines on the continent during the second quarter, where a substantial increase in supplies is expected. One of the reasons, perhaps the greatest one, for the euro’s weakness during the first three months of the year was a suboptimal management of the vaccination program, which compared unfavourably with the smoother UK and US’s roll-outs. However, that looks like it is about to change. This scenario provides an improved outlook for the euro and further strengthening may occur, especially versus the pound, as roles seem to have switched with doubts emerging over the future availability of vaccine supplies in the UK.
Ricardo Evangelista – Senior Analyst, ActivTrades
The support zone of $1,675 worked perfectly for gold, generating a solid rebound. As well as this technical support, gold’s rebound was also helped by a slight decline in US yields, while some short traders probably decided to take profit, closing or reducing their bearish bets on gold. So far, the main trend has not changed and continues to point lower, but we have once again seen that when the price falls below $1,700 buyers react powerfully. A climb above $1,720 would be positive for bullion price, while only a clear recovery above $1,750 would turn around the current bearish outlook.
Carlo Alberto De Casa – Chief analyst, ActivTrades
All information has been prepared by ActivTrades (“AT”). The information does not contain a record of AT’s prices or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance is not a reliable indicator of futures performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk.